European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

EveliQure Biotechnologies GmbH, Vienna, Austria

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

EveliQure Biotechnologies GmbH

Register

Fb
Firmenbuch 380249s

Address

Karl-Farkas-Gasse 22, 1030 Wien, Austria

Corporate purpose

Development of pharmaceuticals, medical Basic Research, Biotechnology

Financials

Earnings Revenue Employees

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Publications

13 Oct 2023
Annual report for the year ending 31/12/2022
13 Jan 2023
Annual report for the year ending 31/12/2021
6 Jul 2022
Annual report for the year ending 31/12/2020
3 Mar 2022
Shareholder (2) · Capital: €36,944
2 Feb 2022
Shareholder (7) · Shareholder (12 companies) · Capital: €36,944
19 Jan 2022
No longer Managing Director: Tamas Zoltan Henics · Capital: €36,944
24 Sept 2021
Patent: High Dose Shigella Vaccine Preparation
17 Jun 2021
Shareholder (3) · Shareholder: Parteurop · Capital: €36,944
5 Mar 2021
Shareholder: BioNet-Asia Ltd. · Capital: €36,944
5 Feb 2021
Annual report for the year ending 31/12/2019
19 Dec 2019
Annual report for the year ending 31/12/2018
1 Sept 2019 in Fts
EU funding (€5,024,395): 815568 - Shigetecvax - Early Clinical Development of a Live, Attenuated Combination Vaccine Against Shigella and Etec Diarrhoea
14 Jun 2019 in Hor
EU funding (€5,024,402): Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea
18 May 2019
Address · Capital: €36,523
2 Feb 2019
Address · Capital: €36,523
20 Nov 2018
Annual report for the year ending 31/12/2017
12 Feb 2018 in Sat
State Aid (€30,176): FFG-RL SMES
12 Feb 2018 in Sat
State Aid (€544,700): FFG-RL SMES
14 Oct 2017
Annual report for the year ending 31/12/2016 (only announcement) · Capital: €36,523
7 Jun 2017
Patent: A Novel Live Attenuated Shigella Vaccine
7 Oct 2016
Annual report for the year ending 31/12/2015 (only announcement) · Capital: €36,523
25 Nov 2015
Shareholder: BioNet-Asia Ltd. · Capital: €36,523
8 Oct 2015
Annual report for the year ending 31/12/2014 (only announcement) · Capital: €35,000
14 Feb 2015
Shareholder (4) · Shareholder (4 companies) · Capital: €35,000
25 Oct 2014
Annual report for the year ending 31/12/2013 (only announcement) · Capital: €35,000
6 Aug 2014
Deadline for annual balance: 31.12. · Capital: €35,000
14 Jun 2014
Managing Director: Gabor Janos Somogyi · Shareholder (3) · No longer Managing Director (1) · No longer Shareholder (1) · Capital: €35,000
8 Jan 2014
Annual report for the year ending 31/03/2013 (only announcement) · Capital: €35,000
5 Sept 2013
Patent: A Novel Live Attenuated Shigella Vaccine
5 Sept 2013
Patent: A Novel Live Attenuated Shigella Vaccine
28 Jul 2012
Capital: €35,000
22 May 2012
Reg­is­tra­tion: 15/05/2012 · SH (4) · MD (2) · Address · Deadline for annual balance: 31.03. · Capital: €35,000 · Seat: Vienna, Austria · Legal form: Gesellschaft mit beschränkter Haftung …

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "EveliQure Biotechnologies GmbH, Vienna, Austria" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close